• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and United States Cardiac Biomarker Market Insights, Forecast to 2026

report cover
  • 3 September 2020
  • Healthcare
  • 127 Pages
  • Report Code: 24LS-21505
  • Formate :   
Download FREE Report Sample Download PDF File

United States Cardiac Biomarker -MARKET ADVISORY SERVICES

Cardiac Biomarker market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Cardiac Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Cardiac Biomarker market is segmented into
Creatine kinase (CK) MB
Troponin (cTnI and cTnT)
BNP & NT-proBNP
Myogloblin
Others (hs-CRP, D-Dimer, etc.)

Segment by Application, the Cardiac Biomarker market is segmented into
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others

Regional and Country-level Analysis
The Cardiac Biomarker market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cardiac Biomarker market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Cardiac Biomarker Market Share Analysis
Cardiac Biomarker market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cardiac Biomarker business, the date to enter into the Cardiac Biomarker market, Cardiac Biomarker product introduction, recent developments, etc.
The major vendors covered:
Abbott
Roche Diagnostics
BG Medicine
Biomerieux
Critical Diagnostics
DiaDexus
Response Biomedical
Siemens Healthcare
Singulex
Thermo Scientific
1 Study Coverage
1.1 Cardiac Biomarker Product Introduction
1.2 Market Segments
1.3 Key Cardiac Biomarker Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cardiac Biomarker Market Size Growth Rate by Type
1.4.2 Creatine kinase (CK) MB
1.4.3 Troponin (cTnI and cTnT)
1.4.4 BNP & NT-proBNP
1.4.5 Myogloblin
1.4.6 Others (hs-CRP, D-Dimer, etc.)
1.5 Market by Application
1.5.1 Global Cardiac Biomarker Market Size Growth Rate by Application
1.5.2 Myocardial Infarction
1.5.3 Congestive Heart Failure
1.5.4 Acute Coronary Syndrome
1.5.5 Atherosclerosis
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Cardiac Biomarker Market Size, Estimates and Forecasts
2.1.1 Global Cardiac Biomarker Revenue 2015-2026
2.1.2 Global Cardiac Biomarker Sales 2015-2026
2.2 Global Cardiac Biomarker, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Cardiac Biomarker Historical Market Size by Region (2015-2020)
2.3.1 Global Cardiac Biomarker Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Cardiac Biomarker Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Cardiac Biomarker Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Cardiac Biomarker Sales Forecast by Region (2021-2026)
2.4.2 Global Cardiac Biomarker Revenue Forecast by Region (2021-2026)

3 Global Cardiac Biomarker Competitor Landscape by Players
3.1 Global Top Cardiac Biomarker Sales by Manufacturers
3.1.1 Global Cardiac Biomarker Sales by Manufacturers (2015-2020)
3.1.2 Global Cardiac Biomarker Sales Market Share by Manufacturers (2015-2020)
3.2 Global Cardiac Biomarker Manufacturers by Revenue
3.2.1 Global Cardiac Biomarker Revenue by Manufacturers (2015-2020)
3.2.2 Global Cardiac Biomarker Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cardiac Biomarker Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cardiac Biomarker Revenue in 2019
3.2.5 Global Cardiac Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Cardiac Biomarker Price by Manufacturers
3.4 Global Cardiac Biomarker Manufacturing Base Distribution, Product Types
3.4.1 Cardiac Biomarker Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cardiac Biomarker Product Type
3.4.3 Date of International Manufacturers Enter into Cardiac Biomarker Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Cardiac Biomarker Market Size by Type (2015-2020)
4.1.1 Global Cardiac Biomarker Sales by Type (2015-2020)
4.1.2 Global Cardiac Biomarker Revenue by Type (2015-2020)
4.1.3 Cardiac Biomarker Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cardiac Biomarker Market Size Forecast by Type (2021-2026)
4.2.1 Global Cardiac Biomarker Sales Forecast by Type (2021-2026)
4.2.2 Global Cardiac Biomarker Revenue Forecast by Type (2021-2026)
4.2.3 Cardiac Biomarker Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cardiac Biomarker Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Cardiac Biomarker Market Size by Application (2015-2020)
5.1.1 Global Cardiac Biomarker Sales by Application (2015-2020)
5.1.2 Global Cardiac Biomarker Revenue by Application (2015-2020)
5.1.3 Cardiac Biomarker Price by Application (2015-2020)
5.2 Cardiac Biomarker Market Size Forecast by Application (2021-2026)
5.2.1 Global Cardiac Biomarker Sales Forecast by Application (2021-2026)
5.2.2 Global Cardiac Biomarker Revenue Forecast by Application (2021-2026)
5.2.3 Global Cardiac Biomarker Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application
6.1 United States Cardiac Biomarker Market Size YoY Growth 2015-2026
6.1.1 United States Cardiac Biomarker Sales YoY Growth 2015-2026
6.1.2 United States Cardiac Biomarker Revenue YoY Growth 2015-2026
6.1.3 United States Cardiac Biomarker Market Share in Global Market 2015-2026
6.2 United States Cardiac Biomarker Market Size by Players (International and Local Players)
6.2.1 United States Top Cardiac Biomarker Players by Sales (2015-2020)
6.2.2 United States Top Cardiac Biomarker Players by Revenue (2015-2020)
6.3 United States Cardiac Biomarker Historic Market Review by Type (2015-2020)
6.3.1 United States Cardiac Biomarker Sales Market Share by Type (2015-2020)
6.3.2 United States Cardiac Biomarker Revenue Market Share by Type (2015-2020)
6.3.3 United States Cardiac Biomarker Price by Type (2015-2020)
6.4 United States Cardiac Biomarker Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Cardiac Biomarker Sales Forecast by Type (2021-2026)
6.4.2 United States Cardiac Biomarker Revenue Forecast by Type (2021-2026)
6.4.3 United States Cardiac Biomarker Price Forecast by Type (2021-2026)
6.5 United States Cardiac Biomarker Historic Market Review by Application (2015-2020)
6.5.1 United States Cardiac Biomarker Sales Market Share by Application (2015-2020)
6.5.2 United States Cardiac Biomarker Revenue Market Share by Application (2015-2020)
6.5.3 United States Cardiac Biomarker Price by Application (2015-2020)
6.6 United States Cardiac Biomarker Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Cardiac Biomarker Sales Forecast by Application (2021-2026)
6.6.2 United States Cardiac Biomarker Revenue Forecast by Application (2021-2026)
6.6.3 United States Cardiac Biomarker Price Forecast by Application (2021-2026)

7 North America
7.1 North America Cardiac Biomarker Market Size YoY Growth 2015-2026
7.2 North America Cardiac Biomarker Market Facts & Figures by Country
7.2.1 North America Cardiac Biomarker Sales by Country (2015-2020)
7.2.2 North America Cardiac Biomarker Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Cardiac Biomarker Market Size YoY Growth 2015-2026
8.2 Europe Cardiac Biomarker Market Facts & Figures by Country
8.2.1 Europe Cardiac Biomarker Sales by Country
8.2.2 Europe Cardiac Biomarker Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Cardiac Biomarker Market Size YoY Growth 2015-2026
9.2 Asia Pacific Cardiac Biomarker Market Facts & Figures by Country
9.2.1 Asia Pacific Cardiac Biomarker Sales by Region (2015-2020)
9.2.2 Asia Pacific Cardiac Biomarker Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Cardiac Biomarker Market Size YoY Growth 2015-2026
10.2 Latin America Cardiac Biomarker Market Facts & Figures by Country
10.2.1 Latin America Cardiac Biomarker Sales by Country
10.2.2 Latin America Cardiac Biomarker Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Cardiac Biomarker Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Cardiac Biomarker Market Facts & Figures by Country
11.2.1 Middle East and Africa Cardiac Biomarker Sales by Country
11.2.2 Middle East and Africa Cardiac Biomarker Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Abbott
12.1.1 Abbott Corporation Information
12.1.2 Abbott Description and Business Overview
12.1.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Abbott Cardiac Biomarker Products Offered
12.1.5 Abbott Recent Development
12.2 Roche Diagnostics
12.2.1 Roche Diagnostics Corporation Information
12.2.2 Roche Diagnostics Description and Business Overview
12.2.3 Roche Diagnostics Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Roche Diagnostics Cardiac Biomarker Products Offered
12.2.5 Roche Diagnostics Recent Development
12.3 BG Medicine
12.3.1 BG Medicine Corporation Information
12.3.2 BG Medicine Description and Business Overview
12.3.3 BG Medicine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 BG Medicine Cardiac Biomarker Products Offered
12.3.5 BG Medicine Recent Development
12.4 Biomerieux
12.4.1 Biomerieux Corporation Information
12.4.2 Biomerieux Description and Business Overview
12.4.3 Biomerieux Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Biomerieux Cardiac Biomarker Products Offered
12.4.5 Biomerieux Recent Development
12.5 Critical Diagnostics
12.5.1 Critical Diagnostics Corporation Information
12.5.2 Critical Diagnostics Description and Business Overview
12.5.3 Critical Diagnostics Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Critical Diagnostics Cardiac Biomarker Products Offered
12.5.5 Critical Diagnostics Recent Development
12.6 DiaDexus
12.6.1 DiaDexus Corporation Information
12.6.2 DiaDexus Description and Business Overview
12.6.3 DiaDexus Sales, Revenue and Gross Margin (2015-2020)
12.6.4 DiaDexus Cardiac Biomarker Products Offered
12.6.5 DiaDexus Recent Development
12.7 Response Biomedical
12.7.1 Response Biomedical Corporation Information
12.7.2 Response Biomedical Description and Business Overview
12.7.3 Response Biomedical Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Response Biomedical Cardiac Biomarker Products Offered
12.7.5 Response Biomedical Recent Development
12.8 Siemens Healthcare
12.8.1 Siemens Healthcare Corporation Information
12.8.2 Siemens Healthcare Description and Business Overview
12.8.3 Siemens Healthcare Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Siemens Healthcare Cardiac Biomarker Products Offered
12.8.5 Siemens Healthcare Recent Development
12.9 Singulex
12.9.1 Singulex Corporation Information
12.9.2 Singulex Description and Business Overview
12.9.3 Singulex Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Singulex Cardiac Biomarker Products Offered
12.9.5 Singulex Recent Development
12.10 Thermo Scientific
12.10.1 Thermo Scientific Corporation Information
12.10.2 Thermo Scientific Description and Business Overview
12.10.3 Thermo Scientific Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Thermo Scientific Cardiac Biomarker Products Offered
12.10.5 Thermo Scientific Recent Development
12.11 Abbott
12.11.1 Abbott Corporation Information
12.11.2 Abbott Description and Business Overview
12.11.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Abbott Cardiac Biomarker Products Offered
12.11.5 Abbott Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Cardiac Biomarker Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cardiac Biomarker Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables

Table 1. Cardiac Biomarker Market Segments

Table 2. Ranking of Global Top Cardiac Biomarker Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Cardiac Biomarker Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)

Table 4. Major Manufacturers of Creatine kinase (CK) MB

Table 5. Major Manufacturers of Troponin (cTnI and cTnT)

Table 6. Major Manufacturers of BNP & NT-proBNP

Table 7. Major Manufacturers of Myogloblin

Table 8. Major Manufacturers of Others (hs-CRP, D-Dimer, etc.)

Table 9. Global Cardiac Biomarker Market Size Growth Rate by Application 2020-2026 (K Units)

Table 10. Global Cardiac Biomarker Market Size by Region (K Units) & (US$ Million): 2020 VS 2026

Table 11. Global Cardiac Biomarker Sales by Regions 2015-2020 (K Units)

Table 12. Global Cardiac Biomarker Sales Market Share by Regions (2015-2020)

Table 13. Global Cardiac Biomarker Revenue by Regions 2015-2020 (US$ Million)

Table 14. Global Cardiac Biomarker Sales Forecast by Region (2021-2026) (K Units)

Table 15. Global Cardiac Biomarker Sales by Manufacturers (2015-2020) (K Units)

Table 16. Global Cardiac Biomarker Sales Share by Manufacturers (2015-2020)

Table 17. Global Cardiac Biomarker Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 18. Global Cardiac Biomarker by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiac Biomarker as of 2019)

Table 19. Cardiac Biomarker Revenue by Manufacturers (2015-2020) (US$ Million)

Table 20. Cardiac Biomarker Revenue Share by Manufacturers (2015-2020)

Table 21. Key Manufacturers Cardiac Biomarker Price (2015-2020) (USD/Unit)

Table 22. Cardiac Biomarker Manufacturers Manufacturing Base Distribution and Headquarters

Table 23. Manufacturers Cardiac Biomarker Product Type

Table 24. Date of International Manufacturers Enter into Cardiac Biomarker Market

Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 26. Global Cardiac Biomarker Sales by Type (2015-2020) (K Units)

Table 27. Global Cardiac Biomarker Sales Share by Type (2015-2020)

Table 28. Global Cardiac Biomarker Revenue by Type (2015-2020) (US$ Million)

Table 29. Global Cardiac Biomarker Revenue Share by Type (2015-2020)

Table 30. Cardiac Biomarker Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)

Table 31. Global Cardiac Biomarker Sales Share by Type (2021-2026)

Table 32. Global Cardiac Biomarker Sales by Application (2015-2020) (K Units)

Table 33. Global Cardiac Biomarker Sales Share by Application (2015-2020)

Table 34. Global Cardiac Biomarker Sales Share by Application (2021-2026)

Table 35. Global Cardiac Biomarker Sales Market Share Forecast by Application (2021-2026)

Table 36. Global Cardiac Biomarker Revenue by Application (2015-2020) (US$ Million)

Table 37. Global Cardiac Biomarker Revenue Market Share Forecast by Application (2021-2026)

Table 38. United States Cardiac Biomarker Sales (K Units) of Key Companies (2015-2020)

Table 39. United States Cardiac Biomarker Sales Share by Company (2015-2020)

Table 40. United States Cardiac Biomarker Revenue (US$ Million) by Company (2015-2020)

Table 41. United States Cardiac Biomarker Sales (K Units) by Type (2015-2020)

Table 42. United States Cardiac Biomarker Sales Share by Type (2015-2020)

Table 43. United States Cardiac Biomarker Revenue (US$ Million) Market Share by Type (2015-2020)

Table 44. United States Cardiac Biomarker Price (K Units) by Type (2015-2020)

Table 45. United States Cardiac Biomarker Sales (K Units) by Type (2021-2026)

Table 46. United States Cardiac Biomarker Sales Share by Type (2021-2026)

Table 47. United States Cardiac Biomarker Revenue (US$ Million) Market Share by Type (2021-2026)

Table 48. United States Cardiac Biomarker Revenue Share by Type (2021-2026)

Table 49. United States Cardiac Biomarker Price (K Units) by Type (2021-2026)

Table 50. United States Cardiac Biomarker Sales (K Units) by Application (2015-2020)

Table 51. United States Cardiac Biomarker Sales Share by Application (2015-2020)

Table 52. United States Cardiac Biomarker Revenue (US$ Million) Market Share by Application (2015-2020)

Table 53. United States Cardiac Biomarker Sales (K Units) by Application (2021-2026)

Table 54. United States Cardiac Biomarker Sales Share by Application (2021-2026)

Table 55. United States Cardiac Biomarker Revenue (US$ Million) Market Share by Application (2021-2026)

Table 56. United States Cardiac Biomarker Revenue Share by Application (2021-2026)

Table 57. North America Cardiac Biomarker Sales by Country (2015-2020) (K Units)

Table 58. North America Cardiac Biomarker Sales Market Share by Country (2015-2020)

Table 59. North America Cardiac Biomarker Revenue by Country (2015-2020) (US$ Million)

Table 60. North America Cardiac Biomarker Revenue Market Share by Country (2015-2020)

Table 61. Europe Cardiac Biomarker Sales by Country (2015-2020) (K Units)

Table 62. Europe Cardiac Biomarker Sales Market Share by Country (2015-2020)

Table 63. Europe Cardiac Biomarker Revenue by Country (2015-2020) (US$ Million)

Table 64. Europe Cardiac Biomarker Revenue Market Share by Country (2015-2020)

Table 65. Asia Pacific Cardiac Biomarker Sales by Region (2015-2020) (K Units)

Table 66. Asia Pacific Cardiac Biomarker Sales Market Share by Region (2015-2020)

Table 67. Asia Pacific Cardiac Biomarker Revenue by Region (2015-2020) (US$ Million)

Table 68. Asia Pacific Cardiac Biomarker Revenue Market Share by Region (2015-2020)

Table 69. Latin America Cardiac Biomarker Sales by Country (2015-2020) (K Units)

Table 70. Latin America Cardiac Biomarker Sales Market Share by Country (2015-2020)

Table 71. Latin Americaa Cardiac Biomarker Revenue by Country (2015-2020) (US$ Million)

Table 72. Latin America Cardiac Biomarker Revenue Market Share by Country (2015-2020)

Table 73. Middle East and Africa Cardiac Biomarker Sales by Country (2015-2020) (K Units)

Table 74. Middle East and Africa Cardiac Biomarker Sales Market Share by Country (2015-2020)

Table 75. Middle East and Africa Cardiac Biomarker Revenue by Country (2015-2020) (US$ Million)

Table 76. Middle East and Africa Cardiac Biomarker Revenue Market Share by Country (2015-2020)

Table 77. Abbott Corporation Information

Table 78. Abbott Description and Business Overview

Table 79. Abbott Cardiac Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 80. Abbott Cardiac Biomarker Product

Table 81. Abbott Recent Development

Table 82. Roche Diagnostics Corporation Information

Table 83. Roche Diagnostics Description and Business Overview

Table 84. Roche Diagnostics Cardiac Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 85. Roche Diagnostics Product

Table 86. Roche Diagnostics Recent Development

Table 87. BG Medicine Corporation Information

Table 88. BG Medicine Description and Business Overview

Table 89. BG Medicine Cardiac Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 90. BG Medicine Product

Table 91. BG Medicine Recent Development

Table 92. Biomerieux Corporation Information

Table 93. Biomerieux Description and Business Overview

Table 94. Biomerieux Cardiac Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 95. Biomerieux Product

Table 96. Biomerieux Recent Development

Table 97. Critical Diagnostics Corporation Information

Table 98. Critical Diagnostics Description and Business Overview

Table 99. Critical Diagnostics Cardiac Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 100. Critical Diagnostics Product

Table 101. Critical Diagnostics Recent Development

Table 102. DiaDexus Corporation Information

Table 103. DiaDexus Description and Business Overview

Table 104. DiaDexus Cardiac Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 105. DiaDexus Product

Table 106. DiaDexus Recent Development

Table 107. Response Biomedical Corporation Information

Table 108. Response Biomedical Description and Business Overview

Table 109. Response Biomedical Cardiac Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 110. Response Biomedical Product

Table 111. Response Biomedical Recent Development

Table 112. Siemens Healthcare Corporation Information

Table 113. Siemens Healthcare Description and Business Overview

Table 114. Siemens Healthcare Cardiac Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 115. Siemens Healthcare Product

Table 116. Siemens Healthcare Recent Development

Table 117. Singulex Corporation Information

Table 118. Singulex Description and Business Overview

Table 119. Singulex Cardiac Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 120. Singulex Product

Table 121. Singulex Recent Development

Table 122. Thermo Scientific Corporation Information

Table 123. Thermo Scientific Description and Business Overview

Table 124. Thermo Scientific Cardiac Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 125. Thermo Scientific Product

Table 126. Thermo Scientific Recent Development

Table 127. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 128. Key Challenges

Table 129. Market Risks

Table 130. Main Points Interviewed from Key Cardiac Biomarker Players

Table 131. Cardiac Biomarker Customers List

Table 132. Cardiac Biomarker Distributors List

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Cardiac Biomarker Product Picture

Figure 2. Global Cardiac Biomarker Sales Market Share by Type in 2020 & 2026

Figure 3. Creatine kinase (CK) MB Product Picture

Figure 4. Troponin (cTnI and cTnT) Product Picture

Figure 5. BNP & NT-proBNP Product Picture

Figure 6. Myogloblin Product Picture

Figure 7. Others (hs-CRP, D-Dimer, etc.) Product Picture

Figure 8. Global Cardiac Biomarker Sales Market Share by Application in 2020 & 2026

Figure 9. Myocardial Infarction

Figure 10. Congestive Heart Failure

Figure 11. Acute Coronary Syndrome

Figure 12. Atherosclerosis

Figure 13. Others

Figure 14. Cardiac Biomarker Report Years Considered

Figure 15. Global Cardiac Biomarker Market Size 2015-2026 (US$ Million)

Figure 16. Global Cardiac Biomarker Sales 2015-2026 (K Units)

Figure 17. Global Cardiac Biomarker Market Size Market Share by Region: 2020 Versus 2026

Figure 18. Global Cardiac Biomarker Sales Market Share by Region (2015-2020)

Figure 19. Global Cardiac Biomarker Sales Market Share by Region in 2019

Figure 20. Global Cardiac Biomarker Revenue Market Share by Region (2015-2020)

Figure 21. Global Cardiac Biomarker Revenue Market Share by Region in 2019

Figure 22. Global Cardiac Biomarker Sales Share by Manufacturer in 2019

Figure 23. The Top 10 and 5 Players Market Share by Cardiac Biomarker Revenue in 2019

Figure 24. Cardiac Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 25. Global Cardiac Biomarker Sales Market Share by Type (2015-2020)

Figure 26. Global Cardiac Biomarker Sales Market Share by Type in 2019

Figure 27. Global Cardiac Biomarker Revenue Market Share by Type (2015-2020)

Figure 28. Global Cardiac Biomarker Revenue Market Share by Type in 2019

Figure 29. Global Cardiac Biomarker Market Share by Price Range (2015-2020)

Figure 30. Global Cardiac Biomarker Sales Market Share by Application (2015-2020)

Figure 31. Global Cardiac Biomarker Sales Market Share by Application in 2019

Figure 32. Global Cardiac Biomarker Revenue Market Share by Application (2015-2020)

Figure 33. Global Cardiac Biomarker Revenue Market Share by Application in 2019

Figure 34. United States Cardiac Biomarker Sales Growth Rate 2015-2026 (K Units)

Figure 35. United States Cardiac Biomarker Revenue Growth Rate 2015-2026 (US$ Million)

Figure 36. United States Cardiac Biomarker Market Share in Global Market 2015-2026

Figure 37. United States 5 and 10 Largest Cardiac Biomarker Players Market Share by Revenue in Cardiac Biomarker in 2019

Figure 38. United States Cardiac Biomarker Revenue Share by Type (2015-2020)

Figure 39. United States Cardiac Biomarker Revenue Growth Rate by Type in 2015 & 2019

Figure 40. United States Cardiac Biomarker Revenue Share by Application (2015-2020)

Figure 41. United States Cardiac Biomarker Revenue Growth Rate by Application in 2015 & 2019

Figure 42. North America Cardiac Biomarker Sales Growth Rate 2015-2020 (K Units)

Figure 43. North America Cardiac Biomarker Revenue Growth Rate 2015-2020 (US$ Million)

Figure 44. North America Cardiac Biomarker Sales Market Share by Country in 2019

Figure 45. North America Cardiac Biomarker Revenue Market Share by Country in 2019

Figure 46. U.S. Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 47. U.S. Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 48. Canada Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 49. Canada Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 50. Europe Cardiac Biomarker Sales Growth Rate 2015-2020 (K Units)

Figure 51. Europe Cardiac Biomarker Revenue Growth Rate 2015-2020 (US$ Million)

Figure 52. Europe Cardiac Biomarker Sales Market Share by Country in 2019

Figure 53. Europe Cardiac Biomarker Revenue Market Share by Country in 2019

Figure 54. Germany Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 55. Germany Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 56. France Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 57. France Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 58. U.K. Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 59. U.K. Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 60. Italy Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 61. Italy Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 62. Russia Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 63. Russia Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 64. Asia Pacific Cardiac Biomarker Sales Growth Rate 2015-2020 (K Units)

Figure 65. Asia Pacific Cardiac Biomarker Revenue Growth Rate 2015-2020 (US$ Million)

Figure 66. Asia Pacific Cardiac Biomarker Sales Market Share by Region in 2019

Figure 67. Asia Pacific Cardiac Biomarker Revenue Market Share by Region in 2019

Figure 68. China Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 69. China Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 70. Japan Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 71. Japan Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 72. South Korea Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 73. South Korea Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 74. India Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 75. India Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 76. Australia Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 77. Australia Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 78. Taiwan Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 79. Taiwan Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 80. Indonesia Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 81. Indonesia Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 82. Thailand Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 83. Thailand Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 84. Malaysia Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 85. Malaysia Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 86. Philippines Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 87. Philippines Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 88. Vietnam Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 89. Vietnam Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 90. Latin America Cardiac Biomarker Sales Growth Rate 2015-2020 (K Units)

Figure 91. Latin America Cardiac Biomarker Revenue Growth Rate 2015-2020 (US$ Million)

Figure 92. Latin America Cardiac Biomarker Sales Market Share by Country in 2019

Figure 93. Latin America Cardiac Biomarker Revenue Market Share by Country in 2019

Figure 94. Mexico Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 95. Mexico Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 96. Brazil Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 97. Brazil Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 98. Argentina Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 99. Argentina Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 100. Middle East and Africa Cardiac Biomarker Sales Growth Rate 2015-2020 (K Units)

Figure 101. Middle East and Africa Cardiac Biomarker Revenue Growth Rate 2015-2020 (US$ Million)

Figure 102. Middle East and Africa Cardiac Biomarker Sales Market Share by Country in 2019

Figure 103. Middle East and Africa Cardiac Biomarker Revenue Market Share by Country in 2019

Figure 104. Turkey Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 105. Turkey Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 106. Saudi Arabia Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 107. Saudi Arabia Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 108. U.A.E Cardiac Biomarker Sales Growth Rate (2015-2020) (K Units)

Figure 109. U.A.E Cardiac Biomarker Revenue Growth Rate (2015-2020) (US$ Million)

Figure 110. Porter's Five Forces Analysis

Figure 111. Cardiac Biomarker Value Chain

Figure 112. Channels of Distribution

Figure 113. Distributors Profiles

Figure 114. Bottom-up and Top-down Approaches for This Report

Figure 115. Data Triangulation

Figure 116. Key Executives Interviewed

Abbott

Roche Diagnostics

BG Medicine

Biomerieux

Critical Diagnostics

DiaDexus

Response Biomedical

Siemens Healthcare

Singulex

Thermo Scientific

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3042

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase